The increasing prevalence of cardiovascular diseases, thrombotic disorders, and stroke risk has significantly elevated the demand for advanced blood-thinning therapies worldwide. Continuous innovation in drug development and the shift toward patient-friendly oral medications are reshaping treatment approaches across healthcare systems. Pharmaceutical companies are also investing in...